{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:05:05Z","timestamp":1767175505636,"version":"build-2238731810"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021QH008"],"award-info":[{"award-number":["ZR2021QH008"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M731484"],"award-info":[{"award-number":["2023M731484"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203218"],"award-info":[{"award-number":["82203218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14236-3","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T03:12:44Z","timestamp":1747019564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Detecting radiation esophagitis using 18F-FAPI-04 PET\/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinying","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengshuai","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"1","key":"14236_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"14236_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"14236_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","volume":"64","author":"M Arnold","year":"2015","unstructured":"Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381\u20137.","journal-title":"Gut"},{"issue":"10","key":"14236_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jjco\/hyh107","volume":"34","author":"K Ishida","year":"2004","unstructured":"Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan esophageal oncology group (JEOG)\/Japan clinical oncology group trial (JCOG9516). Jpn J Clin Oncol. 2004;34(10):615\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"14236_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00268-004-7590-2","volume":"29","author":"H Fujita","year":"2005","unstructured":"Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Matono S, Mori N, Shirouzu K, Yamana H, Suzuki G, Hayabuchi N, et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg. 2005;29(1):25\u201330.","journal-title":"World J Surg"},{"key":"14236_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JSGM Cooper","year":"1999","unstructured":"Cooper JSGM, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85\u2013\u200901).Radiation therapy oncology group. JAMA. 1999;281:1623\u20137.","journal-title":"JAMA"},{"issue":"6s","key":"14236_CR7","first-page":"47","volume":"14","author":"AT Corrado Spatola","year":"2017","unstructured":"Corrado Spatola AT, Antonio P. Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinoma. Future Oncol. 2017;14(6s):47\u201351.","journal-title":"Future Oncol"},{"issue":"18","key":"14236_CR8","first-page":"082","volume":"13","author":"CS Roberto Milazzotto","year":"2018","unstructured":"Roberto Milazzotto CS. Alessandra Tocco metastatic esophagogastric junction cancer: case report of a complete long-term response after combined chemoradiotherapy. EUROMEDITERRANEAN BIOMEDICAL J. 2018;13(18):082\u20134.","journal-title":"EUROMEDITERRANEAN BIOMEDICAL J"},{"issue":"4","key":"14236_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cllc.2011.03.026","volume":"12","author":"M Werner-Wasik","year":"2011","unstructured":"Werner-Wasik M, Paulus R, Curran WJ Jr., Byhardt R. Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database. Clin Lung Cancer. 2011;12(4):245\u201351.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"14236_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.radonc.2008.09.010","volume":"91","author":"J Rose","year":"2009","unstructured":"Rose J, Rodrigues G, Yaremko B, Lock M, D\u2019Souza D. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol. 2009;91(3):282\u20137.","journal-title":"Radiother Oncol"},{"issue":"5\u20136","key":"14236_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteom Clin Appl. 2014;8(5\u20136):454\u201363.","journal-title":"Proteom Clin Appl"},{"issue":"5","key":"14236_CR12","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3892\/mmr.2015.3197","volume":"11","author":"F Zi","year":"2015","unstructured":"Zi F, He J, He D, Li Y, Yang L, Cai Z. Fibroblast activation protein alpha in tumor microenvironment: recent progression and implications (review). Mol Med Rep. 2015;11(5):3203\u201311.","journal-title":"Mol Med Rep"},{"issue":"3","key":"14236_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","volume":"37","author":"PS Acharya","year":"2006","unstructured":"Acharya PS, Zukas A, Chandan V, Katzenstein AL, Pure E. Fibroblast activation protein: a Serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol. 2006;37(3):352\u201360.","journal-title":"Hum Pathol"},{"issue":"12","key":"14236_CR14","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","volume":"60","author":"Z Varasteh","year":"2019","unstructured":"Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, Topping G, Sun T, Nekolla SG, Richter A, et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med. 2019;60(12):1743\u20139.","journal-title":"J Nucl Med"},{"issue":"6","key":"14236_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Rohrich M, Winter H, et al.: 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801\u20135.","journal-title":"J Nucl Med"},{"issue":"8","key":"14236_CR16","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, Wei J, Wu S, Zhao L, Luo Z, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"14236_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.2967\/jnumed.123.266046","volume":"64","author":"SA Koerber","year":"2023","unstructured":"Koerber SA, R\u00f6hrich M, Walkenbach L, Liermann J, Choyke PL, Fink C, Schroeter C, Spektor A-M, Herfarth K, Walle T, et al. Impact of 68Ga-FAPI PET\/CT on staging and oncologic management in a cohort of 226 patients with various cancers. J Nucl Med. 2023;64(11):1712\u201320.","journal-title":"J Nucl Med"},{"key":"14236_CR18","doi-asserted-by":"crossref","unstructured":"Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology 2023, 306(2).","DOI":"10.1148\/radiol.220749"},{"issue":"11","key":"14236_CR19","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1007\/s00259-024-06756-0","volume":"51","author":"H Yuan","year":"2024","unstructured":"Yuan H, Liu E, Zhang G, Lai C, Zhang Q, Shang Y, Cheng Z, Jiang L. Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study. Eur J Nucl Med Mol Imaging. 2024;51(11):3360\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14236_CR20","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00259-022-05758-0","volume":"49","author":"Y Wei","year":"2022","unstructured":"Wei Y, Zheng J, Ma L, Liu X, Xu S, Wang S, Pei J, Cheng K, Yuan S, Yu J. [18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET\/CT imaging of various cancers. Eur J Nucl Med Mol Imaging. 2022;49:2761\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"14236_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/RLU.0000000000003907","volume":"47","author":"X Yang","year":"2022","unstructured":"Yang X, You Z, Mou C, Hu Z, Liu H. Esophagitis mimicking esophageal cancer on 68Ga-FAPI PET\/CT. Clin Nucl Med. 2022;47(3):279\u201380.","journal-title":"Clin Nucl Med"},{"key":"14236_CR22","doi-asserted-by":"crossref","unstructured":"Hu X, Zhou T, Ren J, Duan J, Wu H, Liu X, Mu Z, Liu N, Wei Y, Yuan ST. Response prediction using 18F-FAPI-04 PET\/CT in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. J Nucl Med 2022.","DOI":"10.2967\/jnumed.122.264638"},{"issue":"5","key":"14236_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00259-021-05638-z","volume":"49","author":"Y Wei","year":"2022","unstructured":"Wei Y, Cheng K, Fu Z, Zheng J, Mu Z, Zhao C, Liu X, Wang S, Yu J, Yuan S. [18F]AlF-NOTA-FAPI-04 PET\/CT uptake in metastatic lesions on PET\/CT imaging might distinguish different pathological types of lung cancer. Eur J Nucl Med Mol Imaging. 2022;49(5):1671\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"14236_CR24","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1007\/s00259-016-3505-3","volume":"43","author":"X Luan","year":"2016","unstructured":"Luan X, Huang Y, Gao S, Sun X, Wang S, Ma L, Teng X, Lu H, Yu J, Yuan S. 18F-alfatide PET\/CT May predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2016;43(13):2336\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"14236_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtho.2015.10.006","volume":"11","author":"Q Mehmood","year":"2016","unstructured":"Mehmood Q, Sun A, Becker N, Higgins J, Marshall A, Le LW, Vines DC, McCloskey P, Ford V, Clarke K, et al. Predicting radiation esophagitis using 18F-FDG PET during chemoradiotherapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2016;11(2):213\u201321.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"14236_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.prro.2021.08.004","volume":"12","author":"S Dzul","year":"2022","unstructured":"Dzul S, Ninia J, Jang H, Kim S, Dominello M. Predictors of acute radiation dermatitis and esophagitis in African American patients receiving whole-breast radiation therapy. Pract Radiat Oncol. 2022;12(1):52\u20139.","journal-title":"Pract Radiat Oncol"},{"issue":"13","key":"14236_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28(13):2181\u201390.","journal-title":"J Clin Oncol"},{"issue":"4","key":"14236_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ijrobp.2013.07.029","volume":"87","author":"DA Palma","year":"2013","unstructured":"Palma DA, Senan S, Oberije C, Belderbos J, de Dios NR, Bradley JD, Barriger RB, Moreno-Jimenez M, Kim TH, Ramella S, et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;87(4):690\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"14236_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.5858\/arpa.2014-0111-RS","volume":"139","author":"D Murro","year":"2015","unstructured":"Murro D, Jakate S. Radiation esophagitis. Arch Pathol Lab Med. 2015;139(6):827\u201330.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"14236_CR30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/0360-3016(94)00419-L","volume":"31","author":"LRMR Coia","year":"1995","unstructured":"Coia LRMR, Tepper JE. Late effects of radiation therapy on the Gastrointestinal tract. Int J Radiat Oncol Biol Phys. 1995;31(5):1213\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"14236_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0360-3016(93)90371-2","volume":"27","author":"JDPT Cox","year":"1993","unstructured":"Cox JDPT, Asbell S. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys. 1993;27(3):493\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"14236_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijrobp.2004.06.014","volume":"61","author":"SJ Ahn","year":"2005","unstructured":"Ahn SJ, Kahn D, Zhou S, Yu X, Hollis D, Shafman TD, Marks LB. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys. 2005;61(2):335\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"}],"updated-by":[{"DOI":"10.1186\/s12885-025-14456-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14236-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14236-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14236-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T06:11:48Z","timestamp":1749622308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14236-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14236"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14236-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-025-14456-7","URL":"https:\/\/doi.org\/10.1186\/s12885-025-14456-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was an ongoing prospective clinical study that received ethical approval from the Ethics Committee of Shandong First Medical University Affiliated Cancer Hospital (institutional review board approval no. SDZLEC2021-112-02), and all of participants gave written and informed consent before the study. And this study adhered to the Declaration of Helsinki. This paper has been uploaded to Research Square as a preprint:\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"854"}}